Fexapotide triflutate is an investigational injectable apoptotic agent proposed for the treatment of benign prostatic hypertrophy (BPH).
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Fexapotide triflutate is an investigational injectable apoptotic agent proposed for the treatment of benign prostatic hypertrophy (BPH).
If you have a Hayes login, click here to view the full report on the Knowledge Center.